Back to Results
First PageMeta Content
Orthopedic surgery / Prosthetics / Deep vein thrombosis / Venous thrombosis / Pulmonary embolism / Knee replacement / Thrombosis / Anticoagulant / Hip replacement / Medicine / Hematology / Implants


VTE Risk Post Discharge in Knee & Hip Replacement Patients | Janssen Pharmaceuticals, Inc.
Add to Reading List

Document Date: 2013-11-19 07:14:04

Open Document

File Size: 582,25 KB

Share Result on Facebook

City

Chest Physicians Evidence / /

Company

Janssen Pharmaceuticals Inc. / /

Country

United States / /

Facility

Blood Institute / Hospital Suggestions / Hospital Discharge Planners American College of Chest Physicians / American College of Chest Physicians Evidence-Based Clinical Practice Guidelines / /

MedicalCondition

pain / deep vein thrombosis / Venous Thromboembolism / clinical venous thromboembolism / pulmonary embolism / shortness of breath / chest pains / symptomatic pulmonary embolism / /

MedicalTreatment

hip replacement surgeries / hip replacement / total hip replacement / knee replacement / counseling / surgery / total knee replacement / knee surgeries / surgeries / /

Organization

Hospital Discharge Planners American College of Chest Physicians / American College of Chest Physicians Evidence-Based Clinical Practice Guidelines / National Heart / Lung / and Blood Institute / Guidelines4 American Academy of Orthopaedic Surgeons / /

ProvinceOrState

Prince Edward Island / /

URL

http /

SocialTag